Fig. 4From: NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 miceThe stimulation index given by the MTT test has demonstrated that the 6th group of study has been most affected by the DNA vaccine. (Group1 control: TC1, Group2 control: Sham)Back to article page